Skip to main content
Top
Published in: Sports Medicine 4/2015

01-04-2015 | Review Article

Performance-Enhancing Substances in Sports: A Review of the Literature

Authors: Amit Momaya, Marc Fawal, Reed Estes

Published in: Sports Medicine | Issue 4/2015

Login to get access

Abstract

Performance-enhancing substances (PESs) have unfortunately become ubiquitous in numerous sports, often tarnishing the spirit of competition. Reported rates of PES use among athletes are variable and range from 5 to 31 %. More importantly, some of these substances pose a serious threat to the health and well-being of athletes. Common PESs include anabolic–androgenic steroids, human growth hormone, creatine, erythropoietin and blood doping, amphetamines and stimulants, and beta-hydroxy-beta-methylbutyrate. With recent advances in technology, gene doping is also becoming more conceivable. Sports medicine physicians are often unfamiliar with these substances and thus do not routinely broach the topic of PESs with their patients. However, to effect positive change in the sports community, physicians must educate themselves about the physiology, performance benefits, adverse effects, and testing methods. In turn, physicians can then educate athletes at all levels and prevent the use of potentially dangerous PESs.
Literature
1.
go back to reference Botre F, Pavan A. Enhancement drugs and the athlete. Neurol Clin. 2008;26:149–67.PubMed Botre F, Pavan A. Enhancement drugs and the athlete. Neurol Clin. 2008;26:149–67.PubMed
2.
go back to reference De Rose EH. Doping in athletes: an update. Clin Sports Med. 2008;27:107–30.PubMed De Rose EH. Doping in athletes: an update. Clin Sports Med. 2008;27:107–30.PubMed
4.
go back to reference Mitchell G. Report to the Commissioner of Baseball of an independent investigation into the illegal use of steroids and other performance enhancing substances by players in Major League Baseball (online). http://files.mlb.com/mitchrpt.pdf. Accessed 11 Aug 2014. Mitchell G. Report to the Commissioner of Baseball of an independent investigation into the illegal use of steroids and other performance enhancing substances by players in Major League Baseball (online). http://​files.​mlb.​com/​mitchrpt.​pdf. Accessed 11 Aug 2014.
5.
go back to reference Nilsson S. Androgenic anabolic steroid use among male adolescents in Falkenberg. Eur J Clin Pharmacol. 1995;48:9–11.PubMed Nilsson S. Androgenic anabolic steroid use among male adolescents in Falkenberg. Eur J Clin Pharmacol. 1995;48:9–11.PubMed
6.
go back to reference Korkia P, Stinson GV. Indication of prevalence, practice and effects of anabolic steroid use in Great Britain. Int J Sports Med. 1997;18:557–62.PubMed Korkia P, Stinson GV. Indication of prevalence, practice and effects of anabolic steroid use in Great Britain. Int J Sports Med. 1997;18:557–62.PubMed
7.
go back to reference Simon P, Striegel H, Aust F, et al. Doping in fitness sports: estimated number of unreported cases and individual probability of doping. Addiction. 2006;101:1640–4.PubMed Simon P, Striegel H, Aust F, et al. Doping in fitness sports: estimated number of unreported cases and individual probability of doping. Addiction. 2006;101:1640–4.PubMed
8.
go back to reference Striegel H, Simon P, Frisch S, et al. Anabolic ergogenic substance users in fitness-sports: a distinct group supported by the health care system. Drug Alcohol Depend. 2006;81:11–9.PubMed Striegel H, Simon P, Frisch S, et al. Anabolic ergogenic substance users in fitness-sports: a distinct group supported by the health care system. Drug Alcohol Depend. 2006;81:11–9.PubMed
9.
go back to reference Kanayama G, Gruber AJ, Pope HG Jr, et al. Over-the-counter drug use in gymnasiums: an unrecognized substance abuse problem? Psychother Psychosom. 2001;70:137–40.PubMed Kanayama G, Gruber AJ, Pope HG Jr, et al. Over-the-counter drug use in gymnasiums: an unrecognized substance abuse problem? Psychother Psychosom. 2001;70:137–40.PubMed
10.
go back to reference Buckman JF, Yusko DA, White HR, et al. Risk profile of male college athletes who use performance-enhancing substances. J Stud Alcohol Drugs. 2009;70:919–23.PubMedCentralPubMed Buckman JF, Yusko DA, White HR, et al. Risk profile of male college athletes who use performance-enhancing substances. J Stud Alcohol Drugs. 2009;70:919–23.PubMedCentralPubMed
11.
go back to reference Dietz P, Ulrich R, Dalaker R, et al. Associations between physical and cognitive doping: a cross-sectional study in 2,997 triathletes. PLoS ONE. 2013;8:e78702.PubMedCentralPubMed Dietz P, Ulrich R, Dalaker R, et al. Associations between physical and cognitive doping: a cross-sectional study in 2,997 triathletes. PLoS ONE. 2013;8:e78702.PubMedCentralPubMed
12.
go back to reference Striegel H, Ulrich R, Simon P. Randomized response estimates for doping and illicit drug use in elite athletes. Drug Alcohol Depend. 2010;106:230–2.PubMed Striegel H, Ulrich R, Simon P. Randomized response estimates for doping and illicit drug use in elite athletes. Drug Alcohol Depend. 2010;106:230–2.PubMed
14.
go back to reference Sagoe D, Molde H, Andreassen CS, et al. The global epidemiology of anabolic-androgenic steroid use: a meta analysis and meta-regression analysis. Ann Epidemiol. 2014;24:383–98.PubMed Sagoe D, Molde H, Andreassen CS, et al. The global epidemiology of anabolic-androgenic steroid use: a meta analysis and meta-regression analysis. Ann Epidemiol. 2014;24:383–98.PubMed
15.
go back to reference Gregory AJ, Fitch RW. Sports medicine: performance-enhancing drugs. Pediatr Clin North Am. 2007;54:797–806.PubMed Gregory AJ, Fitch RW. Sports medicine: performance-enhancing drugs. Pediatr Clin North Am. 2007;54:797–806.PubMed
16.
go back to reference Pereira HM, Padilha MC, Neto FR. Tetrahydrogestrinone analysis and designer steroids revisited. Bioanalysis. 2009;1:1475–89.PubMed Pereira HM, Padilha MC, Neto FR. Tetrahydrogestrinone analysis and designer steroids revisited. Bioanalysis. 2009;1:1475–89.PubMed
17.
go back to reference Teale P, Scarth J, Hudson S. Impact of the emergence of designer drugs upon sports doping testing. Bioanalysis. 2012;4:71–88.PubMed Teale P, Scarth J, Hudson S. Impact of the emergence of designer drugs upon sports doping testing. Bioanalysis. 2012;4:71–88.PubMed
18.
go back to reference Tokish JM, Kocher MS, Hawkins RJ. Ergogenic aids: a review of basic science, performance, side effects, and status in sports. Am J Sports Med. 2004;32:1543–53.PubMed Tokish JM, Kocher MS, Hawkins RJ. Ergogenic aids: a review of basic science, performance, side effects, and status in sports. Am J Sports Med. 2004;32:1543–53.PubMed
19.
go back to reference Evans N. Current concepts in anabolic-androgenic steroids. Am J Sports Med. 2004;32:534–42.PubMed Evans N. Current concepts in anabolic-androgenic steroids. Am J Sports Med. 2004;32:534–42.PubMed
20.
go back to reference Bhasin S, Storer TW, Berman N, et al. The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men. N Engl J Med. 1996;335:1–7.PubMed Bhasin S, Storer TW, Berman N, et al. The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men. N Engl J Med. 1996;335:1–7.PubMed
21.
go back to reference Forbes GB, Porta CR, Herr BE, et al. Sequence of changes in body composition induced by testosterone and reversal of changes after drug is stopped. JAMA. 1992;267:397–9.PubMed Forbes GB, Porta CR, Herr BE, et al. Sequence of changes in body composition induced by testosterone and reversal of changes after drug is stopped. JAMA. 1992;267:397–9.PubMed
22.
go back to reference Giorgi A, Weatherby RP, Murphy PW. Muscular strength, body composition and health responses to the use of testosterone enanthate: a double blind study. J Sci Med Sport. 1999;2:341–55.PubMed Giorgi A, Weatherby RP, Murphy PW. Muscular strength, body composition and health responses to the use of testosterone enanthate: a double blind study. J Sci Med Sport. 1999;2:341–55.PubMed
23.
go back to reference Duntas LH, Popovic V. Hormones as doping in sports. Endocrine. 2013;43:303–13.PubMed Duntas LH, Popovic V. Hormones as doping in sports. Endocrine. 2013;43:303–13.PubMed
24.
go back to reference Broeder CE, Quindry J, Brittingham K, et al. The Andro Project: physiological and hormonal influences of androstenedione supplementation in men 35 to 65 years old participating in a high-intensity resistance training program. Arch Intern Med. 2000;160:3093–104.PubMed Broeder CE, Quindry J, Brittingham K, et al. The Andro Project: physiological and hormonal influences of androstenedione supplementation in men 35 to 65 years old participating in a high-intensity resistance training program. Arch Intern Med. 2000;160:3093–104.PubMed
25.
go back to reference King DS, Sharp RL, Vukovich MD, et al. Effect of oral androstenedione on serum testosterone and adaptations to resistance training in young men: a randomized controlled trial. JAMA. 1999;281:2020–8.PubMed King DS, Sharp RL, Vukovich MD, et al. Effect of oral androstenedione on serum testosterone and adaptations to resistance training in young men: a randomized controlled trial. JAMA. 1999;281:2020–8.PubMed
26.
go back to reference Wallace MB, Lim J, Cutler A, et al. Effects of dehydroepiandrosterone vs androstenedione supplementation in men. Med Sci Sports Exerc. 1999;31:1788–92.PubMed Wallace MB, Lim J, Cutler A, et al. Effects of dehydroepiandrosterone vs androstenedione supplementation in men. Med Sci Sports Exerc. 1999;31:1788–92.PubMed
27.
go back to reference Liddle DG, Connor DJ. Nutritional supplements and ergogenic AIDS. Prim Care. 2013;40:487–505.PubMed Liddle DG, Connor DJ. Nutritional supplements and ergogenic AIDS. Prim Care. 2013;40:487–505.PubMed
28.
go back to reference Bahrke MS, Yesalis CE. Abuse of anabolic steroids and related substances in sport and exercise. Curr Opin Pharmacol. 2004;4:614–20.PubMed Bahrke MS, Yesalis CE. Abuse of anabolic steroids and related substances in sport and exercise. Curr Opin Pharmacol. 2004;4:614–20.PubMed
29.
go back to reference Kanayama G, Kean J, Hudson JJ, et al. Cognitive deficits in long-term anabolic-androgenic steroid users. Drug Alcohol Depend. 2013;130:208–14.PubMedCentralPubMed Kanayama G, Kean J, Hudson JJ, et al. Cognitive deficits in long-term anabolic-androgenic steroid users. Drug Alcohol Depend. 2013;130:208–14.PubMedCentralPubMed
30.
go back to reference Geyer H, Schanzer W, Thevis M. Anabolic agents: recent strategies for their detection and protection from inadvertent doping. Br J Sports Med. 2014;48:820–6.PubMedCentralPubMed Geyer H, Schanzer W, Thevis M. Anabolic agents: recent strategies for their detection and protection from inadvertent doping. Br J Sports Med. 2014;48:820–6.PubMedCentralPubMed
31.
go back to reference Brudnak MA. Creatine: are the benefits worth the risk? Toxicol Lett. 2004;150:123–30.PubMed Brudnak MA. Creatine: are the benefits worth the risk? Toxicol Lett. 2004;150:123–30.PubMed
32.
go back to reference Eichner ER. Ergogenic aids: what athletes are using and why. Phys Sportsmed. 1997;25:70–83.PubMed Eichner ER. Ergogenic aids: what athletes are using and why. Phys Sportsmed. 1997;25:70–83.PubMed
33.
go back to reference Greydanus DE, Patel DR. Sports doping in the adolescent athlete the hope, hype, and hyperbole. Pediatr Clin North Am. 2002;49:829–55.PubMed Greydanus DE, Patel DR. Sports doping in the adolescent athlete the hope, hype, and hyperbole. Pediatr Clin North Am. 2002;49:829–55.PubMed
34.
go back to reference Balsom PD, Soderlund K, Sjodin B, et al. Skeletal muscle metabolism during short duration high-intensity exercise: influence of creatine supplementation. Acta Physiol Scand. 1995;154:303–10.PubMed Balsom PD, Soderlund K, Sjodin B, et al. Skeletal muscle metabolism during short duration high-intensity exercise: influence of creatine supplementation. Acta Physiol Scand. 1995;154:303–10.PubMed
35.
go back to reference Birch R, Noble D, Greenhaff PL. The influence of dietary creatine supplementation on performance during repeated bouts of maximal isokinetic cycling in man. Eur J Appl Physiol Occup Physiol. 1994;69:268–76.PubMed Birch R, Noble D, Greenhaff PL. The influence of dietary creatine supplementation on performance during repeated bouts of maximal isokinetic cycling in man. Eur J Appl Physiol Occup Physiol. 1994;69:268–76.PubMed
36.
go back to reference Dawson B, Cutler M, Moody A, et al. Effects of oral creatine loading on single and repeated maximal short sprints. Aust J Sci Med Sport. 1995;27:56–61.PubMed Dawson B, Cutler M, Moody A, et al. Effects of oral creatine loading on single and repeated maximal short sprints. Aust J Sci Med Sport. 1995;27:56–61.PubMed
37.
go back to reference Oliver JM, Joubert DP, Martin SE, et al. Oral creatine supplementation’s decrease of blood lactate during exhaustive, incremental cycling. Int J Sport Nutr Exerc Metab. 2013;23:252–8.PubMed Oliver JM, Joubert DP, Martin SE, et al. Oral creatine supplementation’s decrease of blood lactate during exhaustive, incremental cycling. Int J Sport Nutr Exerc Metab. 2013;23:252–8.PubMed
38.
go back to reference Earnest CP, Snell PG, Rodriguez R, et al. The effect of creatine monohydrate ingestion on anaerobic power indices, muscular strength and body composition. Acta Physiol Scand. 1995;153:207–9.PubMed Earnest CP, Snell PG, Rodriguez R, et al. The effect of creatine monohydrate ingestion on anaerobic power indices, muscular strength and body composition. Acta Physiol Scand. 1995;153:207–9.PubMed
39.
go back to reference Stone MH, Sanborn K, Smith LL, et al. Effects of in-season (5 weeks) creatine and pyruvate supplementation on anaerobic performance and body composition in American football players. Int J Sport Nutr. 1999;9:146–65.PubMed Stone MH, Sanborn K, Smith LL, et al. Effects of in-season (5 weeks) creatine and pyruvate supplementation on anaerobic performance and body composition in American football players. Int J Sport Nutr. 1999;9:146–65.PubMed
40.
go back to reference Aaserud R, Gramyik P, Olsen SR, et al. Creatine supplementation delays onset of fatigue during repeated bouts of sprint running. Scand J Med Sci Sports. 1998;8:247–51.PubMed Aaserud R, Gramyik P, Olsen SR, et al. Creatine supplementation delays onset of fatigue during repeated bouts of sprint running. Scand J Med Sci Sports. 1998;8:247–51.PubMed
41.
go back to reference Mujika I, Chatard JC, Lacoste L, et al. Creatine supplementation does not improve sprint performance in competitive swimmers. Med Sci Sports Exerc. 1996;28:1435–41.PubMed Mujika I, Chatard JC, Lacoste L, et al. Creatine supplementation does not improve sprint performance in competitive swimmers. Med Sci Sports Exerc. 1996;28:1435–41.PubMed
42.
go back to reference Balsom PD, Ekbolm B, Soderlund K, et al. Creatine supplementation and dynamic high-intensity intermittent exercise. Scand J Med Sci Sports. 1993;3:143–9. Balsom PD, Ekbolm B, Soderlund K, et al. Creatine supplementation and dynamic high-intensity intermittent exercise. Scand J Med Sci Sports. 1993;3:143–9.
43.
go back to reference Balsom PD, Soderlund K, Ekblom B. Creatine in humans with special reference to creatine supplementation. Sports Med. 1994;18:268–80.PubMed Balsom PD, Soderlund K, Ekblom B. Creatine in humans with special reference to creatine supplementation. Sports Med. 1994;18:268–80.PubMed
44.
go back to reference Claudino JG, Mezencio B, Amaral S, et al. Creatine monohydrate supplementation on lower-limb muscle power in Brazilian elite soccer players. J Int Soc Sports Nutr. 2014;11:e1–6. Claudino JG, Mezencio B, Amaral S, et al. Creatine monohydrate supplementation on lower-limb muscle power in Brazilian elite soccer players. J Int Soc Sports Nutr. 2014;11:e1–6.
45.
go back to reference Lemon PW. Dietary creatine supplementation and exercise performance: why inconsistent results? Can J Appl Physiol. 2002;27:663–81.PubMed Lemon PW. Dietary creatine supplementation and exercise performance: why inconsistent results? Can J Appl Physiol. 2002;27:663–81.PubMed
46.
go back to reference Dawson B, Vladich T, Blanksby BA. Effects of 4 weeks of creatine supplementation in junior swimmers on freestyle sprint and swim bench performance. J Strength Cond Res. 2002;16:485–90.PubMed Dawson B, Vladich T, Blanksby BA. Effects of 4 weeks of creatine supplementation in junior swimmers on freestyle sprint and swim bench performance. J Strength Cond Res. 2002;16:485–90.PubMed
47.
go back to reference Bailes JE, Cantu RC, Day AL. The neurosurgeon in sport: awareness of the risks of heatstroke and dietary supplements. Neurosurgery. 2002;51:283–6.PubMed Bailes JE, Cantu RC, Day AL. The neurosurgeon in sport: awareness of the risks of heatstroke and dietary supplements. Neurosurgery. 2002;51:283–6.PubMed
48.
go back to reference Wen TC, Hae Tha M, Joo Ng H. Creatine supplementation and venous thrombotic events. Am J Med. 2014; 127;e7–e8. Wen TC, Hae Tha M, Joo Ng H. Creatine supplementation and venous thrombotic events. Am J Med. 2014; 127;e7–e8.
49.
go back to reference Poortmans JR, Francaux M. Long term oral creatine supplementation does not impair renal function in healthy athletes. Med Sci Sports Exerc. 1999;31:1108–10.PubMed Poortmans JR, Francaux M. Long term oral creatine supplementation does not impair renal function in healthy athletes. Med Sci Sports Exerc. 1999;31:1108–10.PubMed
51.
go back to reference Rickert VI, Pawlak-Morello C, Sheppard V, et al. Human growth hormone: a new substance of abuse among adolescents? Clin Pediatr. 1992;31:723–6. Rickert VI, Pawlak-Morello C, Sheppard V, et al. Human growth hormone: a new substance of abuse among adolescents? Clin Pediatr. 1992;31:723–6.
52.
go back to reference Liu H, Bravata DM, Olkin I, et al. Systematic review: the effects of growth hormone on athletic performance. Ann Intern Med. 2008;148:747–58.PubMed Liu H, Bravata DM, Olkin I, et al. Systematic review: the effects of growth hormone on athletic performance. Ann Intern Med. 2008;148:747–58.PubMed
53.
go back to reference Baumann GP. Growth hormone doping in sports: a critical review of use and detection strategies. Endocr Rev. 2012;33:155–86.PubMed Baumann GP. Growth hormone doping in sports: a critical review of use and detection strategies. Endocr Rev. 2012;33:155–86.PubMed
54.
go back to reference Deyssig R, Frisch H, Blum WF, et al. Effect of growth hormone treatment on hormonal parameters, body composition and strength in athletes. Acta Endocrinol. 1993;128:313–8.PubMed Deyssig R, Frisch H, Blum WF, et al. Effect of growth hormone treatment on hormonal parameters, body composition and strength in athletes. Acta Endocrinol. 1993;128:313–8.PubMed
55.
go back to reference Yarasheski KE, Campbell JA, Smith K, et al. Effect of growth hormone and resistance exercise on muscle growth in young men. Am J Physiol. 1992;262:e261–7.PubMed Yarasheski KE, Campbell JA, Smith K, et al. Effect of growth hormone and resistance exercise on muscle growth in young men. Am J Physiol. 1992;262:e261–7.PubMed
56.
go back to reference Rennie MJ. Claims for the anabolic effects of growth hormone: a case of the emperor’s new clothes? Br J Sports Med. 2003;37:100–5.PubMedCentralPubMed Rennie MJ. Claims for the anabolic effects of growth hormone: a case of the emperor’s new clothes? Br J Sports Med. 2003;37:100–5.PubMedCentralPubMed
57.
58.
go back to reference Hanley J, Saarela O, Stephens D, et al. hGH isoform differential immunoassays applied to blood samples from athletes: decision limits for anti-doping testing. Growth Horm IGF Res. 2014;24:205–15.PubMed Hanley J, Saarela O, Stephens D, et al. hGH isoform differential immunoassays applied to blood samples from athletes: decision limits for anti-doping testing. Growth Horm IGF Res. 2014;24:205–15.PubMed
59.
go back to reference Veliz P, Boyd C, McCabe SE. Adolescent athletic participation and nonmedical Adderall use: an exploratory analysis of a performance-enhancing drug. J Stud Alcohol Drugs. 2013;74:714–9.PubMedCentralPubMed Veliz P, Boyd C, McCabe SE. Adolescent athletic participation and nonmedical Adderall use: an exploratory analysis of a performance-enhancing drug. J Stud Alcohol Drugs. 2013;74:714–9.PubMedCentralPubMed
60.
go back to reference Ebert MH, Kammen DP, Murphy DL. Plasma levels of amphetamine and behavioral response. In: Gottschalk LA, Merlis S, editors. Pharmacokinetics of psychoactive drugs: blood levels and clinical response. New York: Wiley; 1976. p. 157–69. Ebert MH, Kammen DP, Murphy DL. Plasma levels of amphetamine and behavioral response. In: Gottschalk LA, Merlis S, editors. Pharmacokinetics of psychoactive drugs: blood levels and clinical response. New York: Wiley; 1976. p. 157–69.
61.
go back to reference Statland BE, Demas TJ. Serum caffeine half-lives: healthy subjects vs. patients having alcohol hepatic disease. Am J Clin Pathol. 1980;73:390–3.PubMed Statland BE, Demas TJ. Serum caffeine half-lives: healthy subjects vs. patients having alcohol hepatic disease. Am J Clin Pathol. 1980;73:390–3.PubMed
62.
go back to reference Haller CA, Jacob P III, Benowitz N. Pharmacology of ephedra alkaloids and caffeine after single-dose dietary supplement use. Clin Pharmacol Ther. 2002;71:421–32.PubMed Haller CA, Jacob P III, Benowitz N. Pharmacology of ephedra alkaloids and caffeine after single-dose dietary supplement use. Clin Pharmacol Ther. 2002;71:421–32.PubMed
63.
go back to reference Pentel P. Toxicity of over-the-counter stimulants. JAMA. 1984;252:1898–903.PubMed Pentel P. Toxicity of over-the-counter stimulants. JAMA. 1984;252:1898–903.PubMed
64.
go back to reference Chandler JV, Blair SN. The effect of amphetamines on selected physiological components related to athletic success. Med Sci Sports Exerc. 1980;12:65–9.PubMed Chandler JV, Blair SN. The effect of amphetamines on selected physiological components related to athletic success. Med Sci Sports Exerc. 1980;12:65–9.PubMed
65.
go back to reference Gill ND, Shield A, Blazevich AJ, et al. Muscular and cardiorespiratory effects of pseudoephedrine in human athletes. Br J Clin Pharmacol. 2000;50:205–13.PubMedCentralPubMed Gill ND, Shield A, Blazevich AJ, et al. Muscular and cardiorespiratory effects of pseudoephedrine in human athletes. Br J Clin Pharmacol. 2000;50:205–13.PubMedCentralPubMed
66.
go back to reference Bell DG, Jacobs I. Combined caffeine and ephedrine ingestion improves run times of Canadian Forces Warrior Test. Aviat Space Environ Med. 1999;70:325–9.PubMed Bell DG, Jacobs I. Combined caffeine and ephedrine ingestion improves run times of Canadian Forces Warrior Test. Aviat Space Environ Med. 1999;70:325–9.PubMed
67.
go back to reference Bell DG, McLellan TM, Sabiston CM. Effect of ingesting caffeine and ephedrine on 10-km run performance. Med Sci Sports Exerc. 2002;34:344–9.PubMed Bell DG, McLellan TM, Sabiston CM. Effect of ingesting caffeine and ephedrine on 10-km run performance. Med Sci Sports Exerc. 2002;34:344–9.PubMed
68.
go back to reference Santos VG, Santos VR, Felippe LJ, et al. Caffeine reduces reaction time and improves performance in simulated-contest of taekwondo. Nutrients. 2014;6:637–49.PubMedCentralPubMed Santos VG, Santos VR, Felippe LJ, et al. Caffeine reduces reaction time and improves performance in simulated-contest of taekwondo. Nutrients. 2014;6:637–49.PubMedCentralPubMed
69.
go back to reference Hodgson AB, Randell RK, Jeukendrup AE. The metabolic and performance effects of caffeine compared to coffee during endurance exercise. PLoS One. 2013;8:e1–10. Hodgson AB, Randell RK, Jeukendrup AE. The metabolic and performance effects of caffeine compared to coffee during endurance exercise. PLoS One. 2013;8:e1–10.
70.
go back to reference Stadheim HK, Kvamme B, Olsen R, et al. Caffeine increases performance in cross-country double-poling time trial exercise. Med Sci Sports Exerc. 2013;45:2175–83.PubMed Stadheim HK, Kvamme B, Olsen R, et al. Caffeine increases performance in cross-country double-poling time trial exercise. Med Sci Sports Exerc. 2013;45:2175–83.PubMed
71.
go back to reference Lee CL, Cheng CF, Astorino TA, et al. Effects of carbohydrate combined with caffeine on repeated sprint cycling and agility performance in female athletes. J Int Soc Sports Nutr. 2014;11:e1–12. Lee CL, Cheng CF, Astorino TA, et al. Effects of carbohydrate combined with caffeine on repeated sprint cycling and agility performance in female athletes. J Int Soc Sports Nutr. 2014;11:e1–12.
72.
go back to reference Reyner LA, Horne JA. Sleep restriction and serving accuracy in performance tennis players and effects of caffeine. Physiol Behav. 2013;120:93–6.PubMed Reyner LA, Horne JA. Sleep restriction and serving accuracy in performance tennis players and effects of caffeine. Physiol Behav. 2013;120:93–6.PubMed
73.
go back to reference Lattavo A, Kopperud A, Rogers PD. Creatine and other supplements. Pediatr Clin North Am. 2007;54:735–60.PubMed Lattavo A, Kopperud A, Rogers PD. Creatine and other supplements. Pediatr Clin North Am. 2007;54:735–60.PubMed
74.
go back to reference Shekelle PG, Hardy ML, Morton SC, et al. Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance: a meta analysis. JAMA. 2003;289:1537–45.PubMed Shekelle PG, Hardy ML, Morton SC, et al. Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance: a meta analysis. JAMA. 2003;289:1537–45.PubMed
75.
go back to reference McDuff DR, Baron D. Substance use in athletics: a sports psychiatry perspective. Clin Sports Med. 2005;24:885–97.PubMed McDuff DR, Baron D. Substance use in athletics: a sports psychiatry perspective. Clin Sports Med. 2005;24:885–97.PubMed
76.
go back to reference Greydanus DE, Patel DR. Sports doping in the adolescent: the Faustian conundrum of Hors de Combat. Pediatr Clin North Am. 2010;57:729–50.PubMed Greydanus DE, Patel DR. Sports doping in the adolescent: the Faustian conundrum of Hors de Combat. Pediatr Clin North Am. 2010;57:729–50.PubMed
78.
go back to reference McLean BD, Gore CJ, Kemp J. Application of ‘live low-train high’ for enhancing normoxic exercise performance in team sport athletes. Sports Med. 2014;44:1275–87.PubMed McLean BD, Gore CJ, Kemp J. Application of ‘live low-train high’ for enhancing normoxic exercise performance in team sport athletes. Sports Med. 2014;44:1275–87.PubMed
79.
go back to reference Morkeberg J. Blood manipulation: current challenges from an anti-doping perspective. Hematol Am Soc Hematol Educ Program. 2013;2013:627–31. Morkeberg J. Blood manipulation: current challenges from an anti-doping perspective. Hematol Am Soc Hematol Educ Program. 2013;2013:627–31.
80.
go back to reference Citartan M, Gopinath SC, Chen Y, et al. Monitoring recombinant human erythropoietin abuse among athletes. Biosens Bioelectron. 2014;63:86–98.PubMed Citartan M, Gopinath SC, Chen Y, et al. Monitoring recombinant human erythropoietin abuse among athletes. Biosens Bioelectron. 2014;63:86–98.PubMed
81.
go back to reference Robertson RJ, Gilcher R, Metz KF, et al. Effect of induced erythrocythemia on hypoxia tolerance during physical exercise. J Appl Physiol Respir Environ Exerc Physiol. 1982;53:490–5.PubMed Robertson RJ, Gilcher R, Metz KF, et al. Effect of induced erythrocythemia on hypoxia tolerance during physical exercise. J Appl Physiol Respir Environ Exerc Physiol. 1982;53:490–5.PubMed
82.
go back to reference Berglund B, Hemmingson P. Effect of reinfusion of autologous blood exercise performance in cross-country skiers. Int J Sports Med. 1987;8:231–3.PubMed Berglund B, Hemmingson P. Effect of reinfusion of autologous blood exercise performance in cross-country skiers. Int J Sports Med. 1987;8:231–3.PubMed
83.
go back to reference Brien AJ, Simon TL. The effects of red blood cell infusion on 10-km race time. JAMA. 1987;257:2761–5.PubMed Brien AJ, Simon TL. The effects of red blood cell infusion on 10-km race time. JAMA. 1987;257:2761–5.PubMed
84.
go back to reference Birkeland KI, Stray-Gundersen J, Hemmerbach P, et al. Effect of rhEPO administration on serum levels of s TfR and cycling performance. Med Sci Sports Exerc. 2000;32:1238–43.PubMed Birkeland KI, Stray-Gundersen J, Hemmerbach P, et al. Effect of rhEPO administration on serum levels of s TfR and cycling performance. Med Sci Sports Exerc. 2000;32:1238–43.PubMed
85.
go back to reference Berglund B, Ekblom B. Effect of recombinant human erythropoietin treatment on blood pressure and some haematological parameters in healthy men. J Intern Med. 1991;229:125–30.PubMed Berglund B, Ekblom B. Effect of recombinant human erythropoietin treatment on blood pressure and some haematological parameters in healthy men. J Intern Med. 1991;229:125–30.PubMed
87.
go back to reference Morkeberg J. Detection of autologous blood transfusions in athletes: a historical perspective. Transfus Med Rev. 2012;26:199–208.PubMed Morkeberg J. Detection of autologous blood transfusions in athletes: a historical perspective. Transfus Med Rev. 2012;26:199–208.PubMed
88.
go back to reference Palisin T, Stacy JJ. Beta-hydroxy-beta-methylbutyrate and its use in athletics. Curr Sports Med Rep. 2005;4:220–3.PubMed Palisin T, Stacy JJ. Beta-hydroxy-beta-methylbutyrate and its use in athletics. Curr Sports Med Rep. 2005;4:220–3.PubMed
89.
go back to reference Pimentel GD, Rosa JC, Lira FS, et al. Beta-hydroxy-beta-methylbutyrate (HMB) supplementation stimulants skeletal muscle hypertrophy in rats via the mTOR pathway. Nutr Metab. 2011;8:e1–7. Pimentel GD, Rosa JC, Lira FS, et al. Beta-hydroxy-beta-methylbutyrate (HMB) supplementation stimulants skeletal muscle hypertrophy in rats via the mTOR pathway. Nutr Metab. 2011;8:e1–7.
90.
go back to reference Smith HJ, Mukerji P, Tisdale MJ. Attenuation of proteasome-induced proteolysis in skeletal muscle by beta-hydroxy-beta-methylbutyrate in cancer-induced muscle loss. Cancer Res. 2005;65:277–83.PubMed Smith HJ, Mukerji P, Tisdale MJ. Attenuation of proteasome-induced proteolysis in skeletal muscle by beta-hydroxy-beta-methylbutyrate in cancer-induced muscle loss. Cancer Res. 2005;65:277–83.PubMed
91.
go back to reference Wilson JM, Kim J, Lee SR, et al. Acute and time effects of beta-hydroxy-beta-methylbutyrate (HMB) on indirect markers of skeletal muscle damage. Nutr Metab. 2009;6:e1–8. Wilson JM, Kim J, Lee SR, et al. Acute and time effects of beta-hydroxy-beta-methylbutyrate (HMB) on indirect markers of skeletal muscle damage. Nutr Metab. 2009;6:e1–8.
92.
go back to reference Knitter AE, Panton I, Rathmacher JA, et al. Effects of beta-hydroxy-beta-methylbutyrate on muscle damage after a prolonged run. J Appl Physiol. 2000;89:1340–4.PubMed Knitter AE, Panton I, Rathmacher JA, et al. Effects of beta-hydroxy-beta-methylbutyrate on muscle damage after a prolonged run. J Appl Physiol. 2000;89:1340–4.PubMed
93.
go back to reference Kraemer WJ, Hatfield DL, Volek JS, et al. Effects of amino acids supplement on physiological adaptations to resistance training. Med Sci Sports Exerc. 2009;41:1111–21.PubMed Kraemer WJ, Hatfield DL, Volek JS, et al. Effects of amino acids supplement on physiological adaptations to resistance training. Med Sci Sports Exerc. 2009;41:1111–21.PubMed
94.
go back to reference Nissen SI, Sharp RL. Effect of dietary supplements on lean mass and strength gains with resistance exercise: a meta-analysis. J Appl Physiol. 2003;94:651–9.PubMed Nissen SI, Sharp RL. Effect of dietary supplements on lean mass and strength gains with resistance exercise: a meta-analysis. J Appl Physiol. 2003;94:651–9.PubMed
95.
go back to reference Hoffman JR, Copper J, Wendell M, et al. Effects of beta-hydroxy-beta-methylbutyrate on power performance and indices of muscle damage and stress during high-intensity training. J Strength Cond Res. 2004;18:747–52.PubMed Hoffman JR, Copper J, Wendell M, et al. Effects of beta-hydroxy-beta-methylbutyrate on power performance and indices of muscle damage and stress during high-intensity training. J Strength Cond Res. 2004;18:747–52.PubMed
96.
go back to reference Kreider RB, Ferreira M, Greenwood M, et al. Effects of calcium b-HMB supplementation during training on markers of body composition, strength, and spring performance. J Exerc Physiology-online. 2000;3:48–59. Kreider RB, Ferreira M, Greenwood M, et al. Effects of calcium b-HMB supplementation during training on markers of body composition, strength, and spring performance. J Exerc Physiology-online. 2000;3:48–59.
97.
go back to reference Wilson JM, Fitschen PJ, Campbell B, et al. International Society of Sports Nutrition position stand: beta-hydroxy-beta-methylbutyrate (HMB). J Int Soc Sports Nutr. 2013;10:e1–14. Wilson JM, Fitschen PJ, Campbell B, et al. International Society of Sports Nutrition position stand: beta-hydroxy-beta-methylbutyrate (HMB). J Int Soc Sports Nutr. 2013;10:e1–14.
98.
go back to reference Gallagher PM, Carrithers JA, Godard MP, et al. Beta-hydroxy-beta-methylbutyrate ingestion, part I: effects on strength and fat free mass. Med Sci Sports Exerc. 2000;32:2109–15.PubMed Gallagher PM, Carrithers JA, Godard MP, et al. Beta-hydroxy-beta-methylbutyrate ingestion, part I: effects on strength and fat free mass. Med Sci Sports Exerc. 2000;32:2109–15.PubMed
99.
go back to reference Nissen S, Sharp RL, Panton L, et al. Beta-hydroxy-beta-methylbutyrate (HMB) supplementation in humans is safe and may decrease cardiovascular risk factors. J Nutr. 2000;130:1937–45.PubMed Nissen S, Sharp RL, Panton L, et al. Beta-hydroxy-beta-methylbutyrate (HMB) supplementation in humans is safe and may decrease cardiovascular risk factors. J Nutr. 2000;130:1937–45.PubMed
100.
go back to reference Van der Gronde T, de Hon O, Haisma HJ, et al. Gene doping: an overview and current implications for athletes. Br J Sports Med. 2013;47:670–8.PubMed Van der Gronde T, de Hon O, Haisma HJ, et al. Gene doping: an overview and current implications for athletes. Br J Sports Med. 2013;47:670–8.PubMed
101.
go back to reference Fischetto G, Bermon S. From gene engineering to gene modulation and manipulation: can we prevent or detect gene doping in sports? Sports Med. 2013;43:965–77.PubMed Fischetto G, Bermon S. From gene engineering to gene modulation and manipulation: can we prevent or detect gene doping in sports? Sports Med. 2013;43:965–77.PubMed
102.
go back to reference Brill-Almon E, Stern B, Afik D, et al. Ex vivo transduction of human dermal tissue structures for autologous implantation production and delivery of therapeutic proteins. Mol Ther. 2005;12:274–82.PubMed Brill-Almon E, Stern B, Afik D, et al. Ex vivo transduction of human dermal tissue structures for autologous implantation production and delivery of therapeutic proteins. Mol Ther. 2005;12:274–82.PubMed
103.
go back to reference Wang W, Li W, Ma N, et al. Non-viral gene delivery methods. Curr Pharm Biotechnol. 2013;14:46–60.PubMed Wang W, Li W, Ma N, et al. Non-viral gene delivery methods. Curr Pharm Biotechnol. 2013;14:46–60.PubMed
104.
go back to reference Sinn PL, Sauter SL, McCray PB Jr. Gene therapy progress and prospects: development of improved lentiviral and retroviral vectors—design, biosafety, and production. Gene Ther. 2005;12:1089–98.PubMed Sinn PL, Sauter SL, McCray PB Jr. Gene therapy progress and prospects: development of improved lentiviral and retroviral vectors—design, biosafety, and production. Gene Ther. 2005;12:1089–98.PubMed
107.
go back to reference Little JC, Perry DR, Volpe SL. Effect of nutrition supplement education on nutrition supplement knowledge among high school students from a low-income community. J Community Health. 2002;27:433–50.PubMed Little JC, Perry DR, Volpe SL. Effect of nutrition supplement education on nutrition supplement knowledge among high school students from a low-income community. J Community Health. 2002;27:433–50.PubMed
108.
go back to reference Whitaker L, Backhouse SH, Long J. Reporting doping in sport: national level athletes’ perceptions of their role in doping prevention. Scan J Med Sci Sports. 2014;24(6):e515–21. Whitaker L, Backhouse SH, Long J. Reporting doping in sport: national level athletes’ perceptions of their role in doping prevention. Scan J Med Sci Sports. 2014;24(6):e515–21.
109.
go back to reference Harcourt PR, Unglik H, Cook JL. Strategy to reduce illicit drug use is effective in elite Australian football. Br J Sports Med. 2012;46:943–5.PubMedCentralPubMed Harcourt PR, Unglik H, Cook JL. Strategy to reduce illicit drug use is effective in elite Australian football. Br J Sports Med. 2012;46:943–5.PubMedCentralPubMed
Metadata
Title
Performance-Enhancing Substances in Sports: A Review of the Literature
Authors
Amit Momaya
Marc Fawal
Reed Estes
Publication date
01-04-2015
Publisher
Springer International Publishing
Published in
Sports Medicine / Issue 4/2015
Print ISSN: 0112-1642
Electronic ISSN: 1179-2035
DOI
https://doi.org/10.1007/s40279-015-0308-9

Other articles of this Issue 4/2015

Sports Medicine 4/2015 Go to the issue